Jingjing Li

Dr. Jingjing Li

Department of Rehabilitation Sciences, Hong Kong Polytechnic University, Hong Kong, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
LWLin-Lin Wang
Lin-Lin Wang
XWXiao-Ran Wang
Xiao-Ran Wang
HWHong-Juan Wang
Hong-Juan Wang
CZChong Zhang
Chong Zhang
JLJingjing Li
Jingjing Li
TLTong-Bu Lu
Tong-Bu Lu

12 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
CZChengwen ZHENG
Chengwen ZHENG
PRPanthakarn Rangsinth
Panthakarn Rangsinth
HSHo Ting Shiu
Ho Ting Shiu
WWWen Wang
Wen Wang
RLRenkai Li
Renkai Li
GLGeorge LEUNG
George LEUNG
Ganoderma lucidum has long been used as a multi-purpose plant and functional food. The pharmacological properties of G. lucidum are primarily attributed to its polysaccharides and triterpenoids. Ganoderic and lucidenic acids are the two major triterpenoids groups in G. lucidum. Despite the discovery of 22 types of lucidenic acids, research on lucidenic acids is significantly less extensive compared to that on ganoderic acid. To the best of our knowledge, for the first time, in this review, we aimed to summarize the sources, contents, chemical structures, and pharmacological effects, including anti-cancer, anti-inflammatory, antioxidant, anti-viral, neuroprotective, anti-hyperlipidemic, anti-hypercholesterolemic, and anti-diabetic properties, of lucidenic acids. Studies on lucidenic acids are still preliminary and have several limitations. Therefore, more in-depth studies with optimal designs are essential for the development of lucidenic acids as medicines, functional foods, and nutraceuticals.

24 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SLSiyao Li
Siyao Li
QCQuanlong Chen
Quanlong Chen
YZYanglin Zhang
Yanglin Zhang
DWDi Wang
Di Wang
HHHuiling Hu
Huiling Hu
JZJinming Zhang
Jinming Zhang
Triptolide (TP), a major active component of the herb Tripterygium wilfordii Hook F, has been shown excellent pharmacological effects on rheumatoid arthritis. However, TP is prone to causing severe organ toxicity, which limits its clinical application. In recent years, microneedle technology has provided a new option for the treatment of arthritis due to its advantages of efficient local transdermal drug delivery. In this study, we constructed a microneedle platform to deliver TP locally to the joints, thereby enhancing TP penetration and reducing systemic toxicity. Additionally, we investigated whether acupoint drug delivery can produce a synergistic effect of needles and drugs. First, TP was loaded into microneedles using polyvinylpyrrolidone and hyaluronic acid as matrix materials. Next, we established a rat adjuvant-induced arthritis (AIA) model to evaluate the therapeutic effect of TP-loaded microneedles. The experiments showed that TP-loaded microneedles alleviated the AIA rats’ inflammatory response, joint swelling, and bone erosion. However, there was no significant difference in the therapeutic effect observed in the acupoint and non-acupoint administration groups. In conclusion, TP-loaded microneedles have the advantages of safety, convenience, and high efficacy over conventional administration routes, laying a foundation for the transdermal drug delivery system-based treatment of rheumatoid arthritis.

31 August 2024 in Phytomedicine
Verified
Journal Article
Closed access
YCYanfen Cheng
Yanfen Cheng
JLJingjing Li
Jingjing Li
XFXi Feng
Xi Feng
YWYihan Wu
Yihan Wu
XWXiaoping Wu
Xiaoping Wu
JZJinming Zhang
Jinming Zhang

1 December 2017 in Phytomedicine
Verified
Journal Article
Closed access
JLJingjing Li
Jingjing Li
JZJinming Zhang
Jinming Zhang
LZLiang Zou
Liang Zou
SLSimon Ming-Yuen Lee
Simon Ming-Yuen Lee
CYCui Yang
Cui Yang
GLGeorge LEUNG
George LEUNG

16 October 2012 in Oncology Letters
Verified
Journal Article
Open access
PDF file
JLJingjing Li
Jingjing Li
QGQi-Hua Gu
Qi-Hua Gu
MLMin Li
Min Li
HYHua-Ping Yang
Hua-Ping Yang
LCLi-Ming Cao
Li-Ming Cao
CHChengping Hu
Chengping Hu
EGCG (epigallocatechin-3-gallate), the major catechin found in green tea, has been demonstrated to inhibit proliferation and induce apoptosis in a number of types of tumors. Recent studies reveal that EGCG has various anticancer effects. This study investigated a further possible molecular mechanism of the anticancer effects of EGCG in murine lung cancer xenografts. In the study, A549 human lung cancer cells were injected into nude mice. Tumor volume was used to measure cancer cell growth. The weight of the animals was used to assess the toxicity of the drugs. The expression of protein and mRNA was assayed by western blot analysis and RT-PCR, respectively. The interaction between Bax and Ku70 was determined by immunoprecipitation. Our results suggest that EGCG induced A549 lung cancer cell apoptosis in vivo, and had less toxic effects compared to classical anticancer drugs. EGCG may inhibit the surrogate markers of proliferation and apoptosis (caspase 3) in A549 tumor xenografts in vivo. In addition, EGCG downregulated the expression of Bcl-xl and upregulated the expression of Bax mRNA and protein. Further experiments indicated that EGCG downregulated the protein expression of Ku70 and interrupted the binding of Ku70 and Bax. This is the first study demonstrating that the induction of apoptosis by EGCG may be caused by the downregulation of Ku70 and that EGCG disrupts the interaction between Ku70 and Bax in lung cancer.